This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Diabetes Mellitus, Type 1
and you are
between 12 and 21
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to determine whether exenatide and pramlintide will improve blood glucose control after meals when compared to insulin alone.

Provided treatments

  • Drug: Insulin
  • Drug: Insulin and Exenatide
  • Drug: Insulin and Pramlintide
Tris trial is registered with FDA with number: NCT00923715. The sponsor of the trial is Baylor College of Medicine and it is looking for 63 volunteers for the current phase.
Official trial title:
Exenatide (Byetta) Vs Pramlintide (Symlin): Role in Post-Prandial Hyperglycemia